Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Ali Duarte-García, Eric L. Matteson, Nilay D. Shah

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalAnnals of internal medicine
Volume171
Issue number8
DOIs
StatePublished - Oct 15 2019

Fingerprint

Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Older Drugs With Limited Trial Evidence : Are They Worth the Expense? / Duarte-García, Ali; Matteson, Eric L.; Shah, Nilay D.

In: Annals of internal medicine, Vol. 171, No. 8, 15.10.2019.

Research output: Contribution to journalArticle

@article{9430fc353bb4439f9e5a93bf16c32c43,
title = "Older Drugs With Limited Trial Evidence: Are They Worth the Expense?",
author = "Ali Duarte-Garc{\'i}a and Matteson, {Eric L.} and Shah, {Nilay D.}",
year = "2019",
month = "10",
day = "15",
doi = "10.7326/L19-0520",
language = "English (US)",
volume = "171",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "8",

}

TY - JOUR

T1 - Older Drugs With Limited Trial Evidence

T2 - Are They Worth the Expense?

AU - Duarte-García, Ali

AU - Matteson, Eric L.

AU - Shah, Nilay D.

PY - 2019/10/15

Y1 - 2019/10/15

UR - http://www.scopus.com/inward/record.url?scp=85073179466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073179466&partnerID=8YFLogxK

U2 - 10.7326/L19-0520

DO - 10.7326/L19-0520

M3 - Article

C2 - 31610565

AN - SCOPUS:85073179466

VL - 171

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 8

ER -